{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Actinomycetes", "Antileishmanial", "Drug discovery", "Marine-resources", "Metagenomic"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34409179", "DateRevised": {"Year": "2023", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "02"}], "Language": ["eng"], "ELocationID": ["e07710", "10.1016/j.heliyon.2021.e07710"], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "7", "Issue": "8", "PubDate": {"Year": "2021", "Month": "Aug"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Bioprospecting marine actinomycetes for antileishmanial drugs: current perspectives and future prospects.", "Pagination": {"StartPage": "e07710", "MedlinePgn": "e07710"}, "Abstract": {"AbstractText": ["Revived analysis interests in natural products in the hope of discovering new and novel antileishmanial drug leads have been driven partially by the increasing incidence of drug resistance. However, the search for novel chemotherapeutics to combat drug resistance had previously concentrated on the terrestrial environment. As a result, the marine environment was often overlooked. For example, actinomycetes are an immensely important group of bacteria for antibiotic production, producing two-thirds of the known antibiotics. However, these bacteria have been isolated primarily from terrestrial sources. Consequently, there have been revived efforts to discover new compounds from uncharted or uncommon environments like the marine ecosystem. Isolation, purification and structure elucidation of target compounds from complex metabolic extract are major challenges in natural products chemistry. As a result, marine-derived natural products from actinomycetes that have antileishmanial bioactivity potentials have been understudied. This review highlights metagenomic and bioassay approaches which could help streamline the drug discovery process thereby greatly reducing time and cost of dereplication to identify suitable antileishmanial drug candidates."], "CopyrightInformation": "\u00a9 2021 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria."}, {"Identifier": [], "Affiliation": "Postdoc Fellow Department of Chemistry, Faculty of Science and Technology, Universitas Airlangga, Komplek Kampus C, Jl. Mulyorejo, Surabaya, 60115, Indonesia."}], "LastName": "Davies-Bolorunduro", "ForeName": "O F", "Initials": "OF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Environmental Metagenomics and Infectious Diseases Research Group (AEMIDR), Department of Biological Sciences, Elizade University, Ilara Mokin, Nigeria."}], "LastName": "Osuolale", "ForeName": "O", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria."}], "LastName": "Saibu", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria."}], "LastName": "Adeleye", "ForeName": "I A", "Initials": "IA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science and Technology, Universitas Airlangga, Komplek Kampus C UNAIR, Jl. Mulyorejo, Surabaya, 60115, Indonesia."}, {"Identifier": [], "Affiliation": "Biotechnology of Tropical Medicinal Plants Research Group, Universitas Airlangga, Indonesia."}], "LastName": "Aminah", "ForeName": "N S", "Initials": "NS"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO Fact Sheet. 2020. www.who.int/news-room/fact-sheets/detail/leishmaniasis"}, {"Citation": "Casalle N., de Barros Pinto Grifoni L., Bosco Mendes A.C., Delort S., Massucato E.M.S. Mucocutaneous leishmaniasis with rare manifestation in the nasal mucosa and cartilage bone septal. Case Rep Infect Dis. 2020 8876020.", "ArticleIdList": ["PMC7528117", "33029438"]}, {"Citation": "Zulfiqar B., Shelper T.B., Avery V.M. Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discov. Today. 2017;10:1516\u20131531.", "ArticleIdList": ["28647378"]}, {"Citation": "Boakye D.A., Wilson M., Kweku M. A\u00a0review of leishmaniasis in West Africa. Ghana Med. J. 2005;39(3):94\u201397.", "ArticleIdList": ["PMC1790817", "17299551"]}, {"Citation": "Bhattacharya S.K., Dash A.P. Elimination of kala-azar from the southeast Asia region. Am. J. Trop. Med. Hyg. 2017;96(4):802\u2013804.", "ArticleIdList": ["0"]}, {"Citation": "Rijal S., Sundar S., Mondal D., Das P., Alvar J., BoelaertM Eliminating visceral leishmaniasis in South Asia: the road ahead. BMJ. 2019;364:k5224.", "ArticleIdList": ["PMC6340338", "30670453"]}, {"Citation": "Maroli M., Rossi L., Baldelli R., Capelli G., Ferroglio E., Genchi C., Gramiccia M., Mortarino M., Pietrobelli M., Gradoni L. The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Trop. Med. Int. Health. 2008;13:256\u2013264.", "ArticleIdList": ["18304273"]}, {"Citation": "Bogdan C., Sch\u00f6nian G., Ba\u00f1uls A.L., Hide M., Pratlong F., Lorenz E., R\u00f6llinghoff M., Mertens R. Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Clin. Infect. Dis. 2001;32:302\u2013306.", "ArticleIdList": ["11170923"]}, {"Citation": "Medlock J.M., Hansford K.M., Bortel W.V., Zeller H., Alten B. A\u00a0summary of the evidence for the change in European distribution of phlebotomine sand flies (Diptera: psychodidae) of public health importance. J.\u00a0Vector Ecol. 2014;39(1):72\u201377.", "ArticleIdList": ["24820558"]}, {"Citation": "Di Muccio T., Scalone A., Bruno A., Marangi M., Grande R. Correction: epidemiology of imported leishmaniasis in Italy: implications for a European endemic country. PloS One. 2015;10(7)", "ArticleIdList": ["PMC4482607", "26114938"]}, {"Citation": "Gkolfinopoulou K., Bitsolas N., Patrinos S., Veneti L., Marka A. Epidemiology of human leishmaniasis in Greece, 1981\u20132011. Euro Surveill. 2013;18(29):20532. pmid:23929118.", "ArticleIdList": ["23929118"]}, {"Citation": "P\u00e9rez-Ayala A., Norman F., P\u00e9rez-Molina J.A., Herrero J.M., Monge B., Lopez-Velez R. Imported leishmaniasis: a heterogeneous group of diseases. J.\u00a0Trav. Med. 2009;16(6):395\u2013401.", "ArticleIdList": ["19930379"]}, {"Citation": "Zlotogorski A., Gilead L., Jonas F., Horev L., Klaus S.N. South American cutaneous leishmaniasis: report of ten cases in Israeli travelers. J.\u00a0Eur. Acad. Dermatol. Venereol. 1998;11(1):32\u201336. PMID: 9731963.", "ArticleIdList": ["9731963"]}, {"Citation": "Oryan A., Akbari M. Worldwide risk factors in leishmaniasis. Asian Pacific Journal of Tropical Medicine. 2016;9(10):925\u2013932.", "ArticleIdList": ["27794384"]}, {"Citation": "Desjeux P. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 1996;14:417\u2013423.", "ArticleIdList": ["8889319"]}, {"Citation": "Kimutai A., Ngure P., Tonui W., Gicheru M. Leishmaniasis in northern and western Africa: a review. African Journal of Infectious Diseases. 2009;3 2009."}, {"Citation": "Consortium Malaria. November 2010. Leishmaniasis Control in Eastern Africa: Past and Present Efforts and Future Needs. Situation and gap Analysis."}, {"Citation": "Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004;27:305\u2013318.", "ArticleIdList": ["15225981"]}, {"Citation": "Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alivar J., Boelart M. Visceral leishmaniasis: what are the needs for diagnosis, treatment, and control? Nat. Rev. Microbiol. 2007;5:873\u2013882.", "ArticleIdList": ["17938629"]}, {"Citation": "Zijlstra E.E., Musa A.M., Khalil E.A., El-hassan I.M., El-hassan A.M. Post-kala-azar dermal leishmaniasis. Lancet Infect. Dis. 2003;3:87\u201398.", "ArticleIdList": ["12560194"]}, {"Citation": "Kone K., Thera M., Faye B., Doumbo O. 2018. Leishmaniases in West Africa: Past and Current."}, {"Citation": "Kone A.K., Niar\u00e9 D.S., Piarroux M. Visceral Leishmaniasis in West Africa: clinical characteristics, vectors, and reservoirs. Journal of Parasitology Research. 2019:8. Article ID 9282690.", "ArticleIdList": ["PMC6745142", "31565426"]}, {"Citation": "Singh S. New developments in diagnosis of leishmaniasis. Indian J. Med. Res. March 2006;123:311\u2013330.", "ArticleIdList": ["16778313"]}, {"Citation": "Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans. R. Soc. Trop. Med. Hyg. May-June 2001;95(3):239\u2013243.", "ArticleIdList": ["11490989"]}, {"Citation": "A\u00eft-Oudhia K., Gazanion E., Vergnes B., Oury B., Sereno D. Leishmania antimony resistance: what we know what we can learn from the field. Parasitol. Res. 2011 Nov;109(5):1225\u20131232. Epub 2011 Jul 29. PMID: 21800124.", "ArticleIdList": ["21800124"]}, {"Citation": "Ponte-Sucre A., Gamarro F., Dujardin J.-C., Barrett M.P., L\u00f3pez-V\u00e9lez R., Garc\u00eda-Hern\u00e1ndez R. Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Neglected Trop. Dis. 2017;11(12)", "ArticleIdList": ["PMC5730103", "29240765"]}, {"Citation": "Mohapatra Sarita. Drug resistance in leishmaniasis: newer developments. Journal of Tropical Parasitology. 2014;4(1):4\u20139.", "ArticleIdList": ["PMC3992802", "24754020"]}, {"Citation": "Shakya N., Bajpai P., Gupta S. Terapeutic switching in Leishmania chemotherapy: a distinct approach towards unsatisfed treatment needs. J.\u00a0Parasit. Dis. 2011;35:104\u2013112.", "ArticleIdList": ["PMC3235389", "23024489"]}, {"Citation": "Alirol E., Schrumpf D., Amici Heradi J., Riedel A., de Patoul C., Quere M., Chappuis F. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: M\u00e9decins Sans Fronti\u00e8res experience in the Democratic Republic of the Congo. Clin. Infect. Dis. 2013;56:195\u2013203.", "ArticleIdList": ["23074318"]}, {"Citation": "Andrews K.T., Fisher G., Skinner-Adams T.S. Drug repurposing and human parasitic protozoan diseases. Int. J. Parasitol. Drugs drug Resist. 2014;4:95\u2013111.", "ArticleIdList": ["PMC4095053", "25057459"]}, {"Citation": "Hamill R.J. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs. 2013;73:919\u2013934.", "ArticleIdList": ["23729001"]}, {"Citation": "Trinconi C.T., Reim\u00e3o J.Q., Yokoyama-Yasunaka J.K.U., Miguel D.C., Uliana S.R.B. Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis. Antimicrob. Agents Chemother. 2014;58:2608\u20132613.", "ArticleIdList": ["PMC3993234", "24550333"]}, {"Citation": "Charlton R.L., Rossi-Bergmann B., Denny P.W., Steel P.G. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art. Parasitology. 2018;145:219\u2013236.", "ArticleIdList": ["PMC5964475", "28805165"]}, {"Citation": "Altamura F., Rajesh R., Catta-Preta C.M.C., Moretti N.S., Cestari I. The current drug discovery landscape for trypanosomiasis and leishmaniasis: challenges and strategies to identify drug targets. Drug Dev. Res. 2020 Apr 6 Epub ahead of print. PMID: 32249457.", "ArticleIdList": ["32249457"]}, {"Citation": "Sundar S. Chakravarty.  2010. J.\u00a0Antimony Toxicity. Int J Environ Res Public Health; pp. 4267\u20134277.http://www.nature.com/scientificreports/%20Scientific%20Reports 7. (2010) 9:438.", "ArticleIdList": ["PMC3037053", "21318007"]}, {"Citation": "Welay G.M., Alene K.A., Dachew B.A. Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia. Epidemiol Health. 2016;39", "ArticleIdList": ["PMC5343104", "28092934"]}, {"Citation": "Patterson S., Wyllie S., Stojanovski L., Perry M.R., Simeons F.R.C., Norval S. The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral leishmaniasis. Antimicrob. Agents Chemother. 2013;57:4699.", "ArticleIdList": ["PMC3811480", "23856774"]}, {"Citation": "Lamotte S., Aulner N., Sp\u00e4th G.F., Prina E. Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening. Sci. Rep. 2019;9(1):438.", "ArticleIdList": ["PMC6345745", "30679614"]}, {"Citation": "De Rycker M., Horn D., Aldridge B., Amewu R.K., Barry C.E., Buckner F.S. Setting our sights on infectious diseases. ACS Infect. Dis. 2020;6:3.", "ArticleIdList": ["PMC6958537", "31808676"]}, {"Citation": "Palaez F. The historical delivery of antibiotics from microbial natural products- can history repeat? Biochm. Pharmacol. 2006;71:981\u2013990.", "ArticleIdList": ["16290171"]}, {"Citation": "Baltz R.H. Marcel Faber Roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration. J.\u00a0Ind. Microbiol. Biotechnol. 2006;33:507\u2013513.", "ArticleIdList": ["16418869"]}, {"Citation": "Koehn F.E., Carter G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005;4:206\u2013220.", "ArticleIdList": ["15729362"]}, {"Citation": "Davies-Bolorunduro O.F., Adeleye I.A., Akinleye M.O., Wang P.G. Anticancer potential of metabolic compounds from marine actinomycetes isolated from Lagos Lagoon sediment. Journal of pharmaceutical analysis. 2019;9(3):201\u2013208.", "ArticleIdList": ["PMC6598170", "31297298"]}, {"Citation": "Ali V., Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by amitochondriate protozoan parasites. Clin. Microbiol. Rev. 2007;20:164\u2013187.", "ArticleIdList": ["PMC1797636", "17223627"]}, {"Citation": "Espinosa A., Socha A.M., Ryke E., Rowley D.C. Antiamoebic properties of the actinomycete metabolites echinomycin A and tirandamycin A. Parasitol. Res. 2012;111(6):2473\u20132477.", "ArticleIdList": ["PMC3491104", "22763704"]}, {"Citation": "Okpekon T., Yolou S., Gleye, Roblot C., Loiseau F., Bories P., Grellier C.P., Frappier F., Laurens A., Hocquemiller R. Antiparasitic activities of medicinal plants used in Ivory Coast. J.\u00a0Ethnopharmacol. 2004;90:91\u201397.", "ArticleIdList": ["14698515"]}, {"Citation": "Billo M., Fournet A., Cabalion P., Waikedre J., Bories C., Loiseau P. Screening of some New Caledonian and Vanuatu medicinal plants for antimycobacterial activity. J.\u00a0Ethnopharmacol. 2005;96:569\u2013575.", "ArticleIdList": ["15588670"]}, {"Citation": "Monzote L., Garc\u0131\u00b4a M., Montalvo A.M., Scull R., Miranda M., Abreu J. In vitro activity of an essential oil against Leishmania donovani. Phytother Res. 2007;21:1055\u20131058.", "ArticleIdList": ["17724767"]}, {"Citation": "Ogungbe I.V., Singh M., Setzer W.N. Antileishmanial natural products from plants. Stud. Nat. Prod. Chem. 2012:331\u2013382."}, {"Citation": "Malak L.G., Ibrahim M.A., Moharram A.M., Pandey P., Tekwani B., Doerksen R.J., Ross S.A. Antileishmanial carbasugars from Geosmithia langdonii. J.\u00a0Nat. Prod. 2018", "ArticleIdList": ["30298736"]}, {"Citation": "Bhatnagar I., Kim S.-K. Pharmacologically prospective antibiotic agents and their sources: a marine microbial perspective. Environ. Toxicol. Pharmacol. 2012;34:631\u2013643.", "ArticleIdList": ["23121870"]}, {"Citation": "Qasim S.Z. Oxford and IBH; New Delhi: 1999. The Indian Ocean: Images and Realities; pp. 57\u201390."}, {"Citation": "Subramani A., Aalbersberg W. Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiol. Res. 2012;167(10):571\u2013580. ISSN 0944-5013.", "ArticleIdList": ["22796410"]}, {"Citation": "Fenical W., Jensen P.R. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2006;2(12):666\u2013673.", "ArticleIdList": ["17108984"]}, {"Citation": "Berdy J. Bioactive microbial metabolites. J.\u00a0Antibiot. 2005;58:1\u201326.", "ArticleIdList": ["15813176"]}, {"Citation": "Zahner H., Fiedler H.P. Fifty years of antimicrobials: past perspectives and future trends. In: Hunter P.A., Darby G.K., Russell N.J., editors. The Need for New Antibiotics: Possible Ways Forward. Fifty-Third Symposium of the Society for General Microbiology bath. Cambridge University Press; Cambridge, UK: 1995. pp. 67\u201384."}, {"Citation": "Ventura M., Canchaya C., Tauch A., Chandra G., Fitzgerald G.F., Chater K.F., van Sinderen D. Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol. Mol. Biol. Rev. 2007;71:495\u2013548.", "ArticleIdList": ["PMC2168647", "17804669"]}, {"Citation": "Ludwig W., Euz\u00e9by J., Schumann P., Buss H.J., Trujillo M.E., K\u00e4mpfer P., Whiteman W.B. Road map of the phylum Actinobacteria, p 1\u201328. In: Goodfellow M., K\u00e4mpfer P., Busse H.J., Trujillo M.E., Suzuki K.I., Ludwig W., Whitman W.B., editors. Vol. 5. Springer-Verlag; New York, NY: 2012. (Bergey's Manual of Systematic Bacteriology)."}, {"Citation": "Barka E.A., Vatsa P., Sanchez L., Gaveau-Vaillant N., Jacquard C., Klenk H.-P., Cl\u00e9ment C., Ouhdouch Y., van Wezel G.P. Taxonomy, physiology, and natural products of Actinobacteria. Microbiol. Mol. Biol. Rev. 2016;80:1\u201343.", "ArticleIdList": ["PMC4711186", "26609051"]}, {"Citation": "McCarthy A.J., Williams S.T. Actinomycetes as agents of biodegradation in the environment-a review. Gene. 1992;115:189\u2013192.", "ArticleIdList": ["1612435"]}, {"Citation": "Schrempf H. Recognition and degradation of chitin by streptomycetes. Antonie Leeuwenhoek. 2001;79:285\u2013289.", "ArticleIdList": ["11816971"]}, {"Citation": "Janardhan A., Kumar A.P., Viswanath B., Saigopal D.V.R., Narasimha G. Production of bioactive compounds by actinomycetes and their antioxidant properties. Biotechnology Research International. 2014;2014:217030.", "ArticleIdList": ["PMC3984769", "24790761"]}, {"Citation": "Otoguro K., Ishiyama A., Namatame M., Nishihara A., Furusawa T., Masuma R. Selective and potent in vitro antitrypanosomal activities of ten microbial metabolites. J.\u00a0Antibiot. (Tokyo) 2008 Jun;61(6):372\u2013378.", "ArticleIdList": ["18667785"]}, {"Citation": "Prudhomme J., McDaniel E., Ponts N., Bertani S., Fenical W., Jensen P., Le Roch K. Marine actinomycetes: a new source of compounds against the human malaria parasite. PloS One. 2008 Jun 4;3(6)", "ArticleIdList": ["PMC2391291", "18523554"]}, {"Citation": "Huang H., Yao Y., He Z., Yang T., Ma J., Tian X. Antimalarial \u03b2-carboline and indolactam alkaloids from Marinactinospora thermotolerans, a deep-sea isolate. J.\u00a0Nat. Prod. 2011;74:2122\u20132127.", "ArticleIdList": ["21977916"]}, {"Citation": "Ortega H.E., Lourenzon V.B., Chevrette M.G., Ferreira L.L.G., Alvarenga R.F.R., Melo W.G.P., Ven\u00e2ncio T., Currie C.R., Andricopulo A.D., Bugni T.S., Pupo M.T. Antileishmanial macrolides from ant-associated Streptomyces sp. ISID311. Bioorg. Med. Chem. 2021;32:116016.", "ArticleIdList": ["PMC7923958", "33493972"]}, {"Citation": "Pimentel-Elardo S.M., Kozytska S., Bugni T.S., Ireland C.M., Moll H., Hentschel U. Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges. Mar. Drugs. 2010;8:373\u2013380.", "ArticleIdList": ["PMC2852844", "20390111"]}, {"Citation": "Tempone A., Martins de Oliveira C., Berlinck R. Current approaches to discover marine antileishmanial natural products. Planta Med. 2011;77(6):572\u2013585.", "ArticleIdList": ["21243582"]}, {"Citation": "Regalado E.L., Tasdemir D., Kaiser M., Cachet N., Amade P., Thomas O.P. Antiprotozoal steroidal saponins from the marine sponge Pandaros acanthifolium. J.\u00a0Nat. Prod. 2010;73:1404\u20131410.", "ArticleIdList": ["20614907"]}, {"Citation": "Yang F., Hamann M.T., Zou Y., Zhang M.Y., Gong X.B., Xiao J.R. Antimicrobial metabolites from the paracel islands sponge Agelas mauritiana. J.\u00a0Nat. Prod. 2012;75:774\u2013778.", "ArticleIdList": ["PMC4883697", "22360686"]}, {"Citation": "Scala F., Fattorusso E., Menna M., Taglialatela-Scafati O., Tierney M., Kaiser M. Bromopyrrole alkaloids as lead compounds against protozoan parasites. Mar. Drugs. 2010;8:2162\u20132174.", "ArticleIdList": ["PMC2920549", "20714430"]}, {"Citation": "Fran\u00e7a P.H., da Silva-J\u00fanior E.F., Santos B.V., Alexandre-Moreira M.S., Quintans-Junior L.J., de Aquino T.M., de Araujo-Junior J.X. Antileishmanial marine compounds: a review. Record Nat. Prod. 2017;11:92."}, {"Citation": "Orhan I., Sener B., Kaiser M., Brun R., Tasdemir D. Inhibitory activity of marine sponge-derived natural products against parasitic protozoa. Mar. Drugs. 2010;8:47\u201358.", "ArticleIdList": ["PMC2817922", "20161970"]}, {"Citation": "Liu X.F., Shen Y., Yang F., Hamann M.T., Jiao W.H., Zhang H.J. Simplexolides A-E and plakorfuran A, six butyrate derived polyketides from the marine sponge Plakortis simplex. Tetrahedron. 2012;68:4635\u20134640.", "ArticleIdList": ["PMC5114024", "27867228"]}, {"Citation": "Parra L.L.L., Bertonha A.F., Severo I.R.M., Aguiar A.C.C., De Souza G.E., Oliva G. Isolation, derivative synthesis, and structure-activity relationships of antiparasitic bromopyrrole alkaloids from the marine sponge Tedania brasiliensis. J.\u00a0Nat. Prod. 2018;81:188\u2013202.", "ArticleIdList": ["PMC5989537", "29297684"]}, {"Citation": "Imperatore C., Gimmelli R., Persico M., Casertano M., Guidi A., Saccoccia F. Investigating the antiparasitic potential of the marine sesquiterpene avarone, its reduced form avarol, and the novel semisynthetic thiazinoquinone analogue thiazoavarone. Mar. Drugs. 2020;18:112.", "ArticleIdList": ["PMC7074381", "32075136"]}, {"Citation": "Nweze J.A., Mbaoji F.N., Li Y.M., Yang L.Y., Huang S.S., Chigor V.N., Eze E.A., Pan L.X., Zhang T., Yang D.F. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles. Infectious Diseases of Poverty. 2021;10:1\u201319.", "ArticleIdList": ["PMC7821695", "33482912"]}, {"Citation": "Osei E., Kwain S., Mawuli G., Anang A., Owusu K., Camas M. Paenidigyamycin A, potent antiparasitic imidazole alkaloid from the Ghanaian Paenibacillus sp. DE2SH. Mar Drugs. 2018;17:9.", "ArticleIdList": ["PMC6356793", "30586918"]}, {"Citation": "Cartuche L., Sifaoui I., Lopez-Arencibia A., Bethencourt-Estrella C.J., San Nicolas-Hernandez D., Lorenzo-Morales J. Antikinetoplastid activity of indolocarbazoles from Streptomyces sanyensis. Biomolecules. 2020;10:657.", "ArticleIdList": ["PMC7226613", "32344693"]}, {"Citation": "Sreedharan V., Rao K.V.B. Efficacy of protease inhibitor from marine Streptomyces sp. VITBVK2 against Leishmania donovani \u2013 an invitro study. Exp. Parasitol. 2017;174:45\u201351.", "ArticleIdList": ["28167209"]}, {"Citation": "Galindo-Cabello N.R., Palomino N.R., G\u00f3mez G.M., Quispe J.L. 64th Annual Meeting Held on October 25-29, 2015. American Society of Tropical Medicine and Hygiene; Philadelphia, Pennsylvania, USA: 2015. Antiparasitic potential of extracellular metabolites from marine actinomycetes against Leishmania (Viannia) peruviana and Leishmania (V.) braziliensis."}, {"Citation": "Popplewell W.L., Ratnayake R., Wilson J.A., Beutler J.A., Colburn N.H., Henrich C.J. Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula. J.\u00a0Nat. Prod. 2011;74:1686\u20131691.", "ArticleIdList": ["PMC3162996", "21806011"]}, {"Citation": "Vinothkumar S., Parameswaran P.S. Recent advances in marine drug research. Biotechnol. Adv. 2013;31:1826\u20131845.", "ArticleIdList": ["23500952"]}, {"Citation": "Balunas M.J., Linington R.G., Tidgewell K., Fenner A.M., Urena L.D., Della Togna G. Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. J.\u00a0Nat. Prod. 2010;73:60\u201366.", "ArticleIdList": ["PMC2834186", "20030365"]}, {"Citation": "Sanchez L.M., Lopez D., Vesely B.A., Della Togna G., Gerwick W.H., Kyle D.E. Almiramides A\u2013C: discovery and development of a new class of leishmaniasis lead compounds. J.\u00a0Med. Chem. 2010;53:4187\u20134197.", "ArticleIdList": ["PMC4418807", "20441198"]}, {"Citation": "Simmons T.L., Engene N., Urena L.D., Romero L.I., Ortega-Barria E., Gerwick L. Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis. J.\u00a0Nat. Prod. 2008;71:1544\u20131550.", "ArticleIdList": ["PMC2656441", "18715036"]}, {"Citation": "Balunas M.J., Grosso M.F., Villa F.A., Engene N., McPhail K.L., Tidgewell K. Coibacins A-D, antileishmanial marine cyanobacterial polyketides with intriguing biosynthetic origins. Org. Lett. 2012;14:3878\u20133881.", "ArticleIdList": ["PMC3449157", "22794317"]}, {"Citation": "Smyrniotopoulos V., Merten C., Kaiser M., Tasdemir D. Bifurcatriol, a new antiprotozoal acyclic diterpene from the brown alga Bifurcaria bifurcata. Mar. Drugs. 2017;15:1\u201310.", "ArticleIdList": ["PMC5577600", "28767061"]}, {"Citation": "Chiboub O., Sifaoui I., Lorenzo-Morales J., Abderrabba M., Mejri M., Fernandez J.J. Spiralyde A, an antikinetoplastid dolabellane from the brown alga Dictyota spiralis. Mar. Drugs. 2019;17:1\u201311.", "ArticleIdList": ["PMC6471066", "30934651"]}, {"Citation": "Bruno de Sousa C., Gangadhar K.N., Morais T.R., Conserva G.A.A., Vizetto-Duarte C., Pereira H. Antileishmanial activity of meroditerpenoids from the macroalgae Cystoseira baccata. Exp. Parasitol. 2017;174:1\u20139.", "ArticleIdList": ["28126391"]}, {"Citation": "Soares D.C., Szlachta M.M., Teixeira V.L., Soares A.R., Saraiva E.M. The brown alga stypopodium zonale (dictyotaceae): a potential source of antileishmanial drugs. Mar. Drugs. 2016;14:1\u201311.", "ArticleIdList": ["PMC5039534", "27618071"]}, {"Citation": "Diaz-Marrero A.R., Lopez-Arencibia A., Bethencout-Estrella C.J., Cen-Pacheco F., Sifaoui I., Hernandez Creus A. Antiprotozoal activities of marine polyether triterpenoids. Bioorg. Chem. 2019;92:10327.", "ArticleIdList": ["31539745"]}, {"Citation": "Gao J., Radwan M.M., Le\u00f3n F., Wang X., Jacob M.R., Tekwani B.L. Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens. Med. Chem. Res. 2012;21:3080\u20133086.", "ArticleIdList": ["PMC3457657", "23024574"]}, {"Citation": "Braun G.H., Ramos H.P., Candido A.C.B.B., Pedroso R.C.N., Siqueira K.A., Soares M.A. Evaluation of antileishmanial activity of harzialactone isolated from the marine-derived fungus Paecilomyces sp. Nat. Prod. Res. 2019", "ArticleIdList": ["31140307"]}, {"Citation": "Da Silva MacHado F.L., Pacienza-Lima W., Rossi-Bergmann B., De Souza Gestinari L.M., Fujii M.T., Paula J.C. Antileishmanial sesquiterpenes from the Brazilian red alga Laurencia dendroidea. Planta Med. 2011;77:733\u2013735.", "ArticleIdList": ["21058243"]}, {"Citation": "Dos Santos A.O., Britta E.A., Bianco E.M., Ueda-Nakamura T., Dias Filho B.P., Pereira R.C. 4-Acetoxydolastane diterpene from the Brazilian brown alga Canistrocarpus cervicornis as antileishmanial agent. Mar. Drugs. 2011;9:2369\u20132383.", "ArticleIdList": ["PMC3229239", "22163190"]}, {"Citation": "Soares D.C., Calegari-Silva T.C., Lopes U.G., Teixeira V.L., Paix\u00e3o I.C.N.P., Cirne-Santos C. Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis. PLoS Neglected Trop. Dis. 2012;6", "ArticleIdList": ["PMC3435235", "22970332"]}, {"Citation": "Subramani R., Aalbersberg W. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery. Appl. Microbiol. Biotechnol. 2013;97:9291\u20139321.", "ArticleIdList": ["24057404"]}, {"Citation": "Maldonado L.A., Fenical W., Jensen P.R., Kauffman C.A., Mincer T.J., Ward A.C., Bull A.T., Goodfellow M. Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligate marine actinomycetes belonging to the family Micromonosporaceae. Int. J. Syst. Evol. Microbiol. 2005;55:1759\u20131766.", "ArticleIdList": ["16166663"]}, {"Citation": "Hames-Kocabas E.E., Uzel A. Isolation strategies of marine-derived actinomycetes from sponge and sediment samples. J.\u00a0Microbiol. Methods. 2012;88:342\u2013347.", "ArticleIdList": ["22285852"]}, {"Citation": "Azman A.S., Zainal N., Mutalib N.A., Yin W.F., Chan K.G., Lee L.H. Monashia flava gen. nov., sp. nov., an actinobacterium of the family Intrasporangiaceae. Int. J. Syst. Evol. Microbiol. 2016;66:554\u2013561.", "ArticleIdList": ["26556816"]}, {"Citation": "Lai H., Jiang Y., Chen X., Li Q., Jiang C., Jiang Y., Wei X. Haloactinomyces albus gen. nov., sp. nov., isolated from the dead sea. Int. J. Syst. Evol. Microbiol. 2017;67:1163\u20131168.", "ArticleIdList": ["28073400"]}, {"Citation": "Tiwari K., Gupta R.K. Diversity and isolation of rare Actinomycetes: an overview. Crit. Rev. Microbiol. 2012;39:256\u2013294.", "ArticleIdList": ["22901022"]}, {"Citation": "Wang S., Zhou Y., Zhang G. Nocardioides flavus sp. nov., isolated from marine sediment. Int. J. Syst. Evol. Microbiol. 2016;66:5275\u20135280.", "ArticleIdList": ["27654931"]}, {"Citation": "Claver\u00edas F.P., Undabarrena A., Gonz\u00e1lez M., Seeger M., C\u00e1mara B. Culturable diversity and antimicrobial activity of Actinobacteria from marine sediments in Valpara\u00edso bay, Chile. Front. Microbiol. 2015;6:737.", "ArticleIdList": ["PMC4516979", "26284034"]}, {"Citation": "Subramani R., Sipkema D. Marine rare actinomycetes: a promising source of structurally diverse and unique novel natural products. Mar. Drugs. 2019;17:249.", "ArticleIdList": ["PMC6562664", "31035452"]}, {"Citation": "Aoi, Y., Kinoshita, T., Hata, T., Ohta, H., Obokata, H. and Tsuneda, S. Hollow-fiber membrane chamber as a device for in situ environmental cultivation. Appl. Environ. Microbiol. 75: 3826\u20133833.", "ArticleIdList": ["PMC2687273", "19329655"]}, {"Citation": "Nichols D., Cahoon N., Trakhtenberg E.M., Pham L., Mehta A., Belanger A. Use of ichip for high-throughput in situ cultivation of \u201cuncultivable\u201d microbial species. Appl. Environ. Microbiol. 2010;76:2445\u20132450.", "ArticleIdList": ["PMC2849220", "20173072"]}, {"Citation": "Ling L.L., Schneider T., Peoples A.J., Spoering A.L., Engels I., Conlon B.P. A\u00a0new antibiotic kills pathogen without detectable resistance. Nature. 2015;517:455\u2013459.", "ArticleIdList": ["PMC7414797", "25561178"]}, {"Citation": "Sherpa R.T., Reese C.J., Aliabadi H.M. Application of iChip to grow \u201cuncultivable\u201d microorganisms and its impact on antibiotic discovery. J.\u00a0Pharm. Pharmaceut. Sci. 2015;18:303\u2013315.", "ArticleIdList": ["26517134"]}, {"Citation": "Arias C.A., Murray B.E. A\u00a0new antibiotic and the evolution of resistance. N.\u00a0Engl. J. Med. 2015;372:1168\u20131170.", "ArticleIdList": ["PMC4433155", "25785976"]}, {"Citation": "Soto J., Arana B.A., Toledo J., Rizzo N., Vega J.C., Diaz A. Miltefosine for new world cutaneous leishmaniasis. Clin. Infect. Dis. 2004;38:1266\u20131272.", "ArticleIdList": ["15127339"]}, {"Citation": "Lima E.B. Tratamento da leishmaniose tegumentar Americana. An. Bras. Dermatol. 2007;82:111\u2013124."}, {"Citation": "Ganguly S., Bandyopadhyay S., Sarkar A., Chatterjee M. Development of a semiautomated colorimetric assay for screening anti-leishmanial agents. J.\u00a0Microbiol. Methods. 2005;66:78\u201386.", "ArticleIdList": ["16316700"]}, {"Citation": "Sereno D., Lemesre J.L. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob. Agents Chemother. 1997;41:972\u2013976.", "ArticleIdList": ["PMC163835", "9145854"]}, {"Citation": "Mikus J., Steverding D. A\u00a0simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitol. Int. 2000;48:265\u2013269.", "ArticleIdList": ["11227767"]}, {"Citation": "Rezende N., Ceron Jayme C., Brassesco M.S., Claudio Tedesco A., de Oliveira H.F. Standardization of a resazurin-based assay for the evaluation of metabolic activity in oral squamous carcinoma and glioblastoma cells. Photodiagnosis Photodyn. Ther. 2019;26:371\u2013374.", "ArticleIdList": ["31063861"]}, {"Citation": "Kram D., Th\u00e4le C., Kolodziej H., Kiderlen A.F. Intracellular parasite kills: flow cytometry and NO detection for rapid discrimination between antileishmanial activity and macrophage activation. J.\u00a0Immunol. Methods. 2008;20:79\u201388.", "ArticleIdList": ["18313691"]}, {"Citation": "Seifert K., Escobar P., Croft S.L. In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent. J.\u00a0Antimicrob. Chemother. 2010;65:508\u2013511.", "ArticleIdList": ["20089542"]}, {"Citation": "Naylor L.H. Reporter gene technology: the future looks bright. Biochem. Pharmacol. 1999;58:749\u2013757.", "ArticleIdList": ["10449183"]}, {"Citation": "Handman E., Spira D.T. Growth of Leishmania amastigotes in macrophages from normal and immune mice. Z.\u00a0Parasitenkd. 1977;25:75\u201381.", "ArticleIdList": ["919689"]}, {"Citation": "Ghosh A.K., Bhattacharyya F.K., Ghosh D.K. Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp. Parasitol. 1985;60:404\u2013413.", "ArticleIdList": ["4076392"]}, {"Citation": "Messaritakis I., Mazeris A., Koutala E., Antoniou M. Leishmania donovani s.l.: evaluation of the proliferation potential of promastigotes using CFSE staining and flow cytometry. Exp. Parasitol. 2010;125:384\u2013388.", "ArticleIdList": ["20303953"]}, {"Citation": "Garner D.L., Johnson L.A., Yue S.T., Roth B.L., Haugland R.P. Dual DNA staining assessment of bovine sperm viability using SYBR-14 and propidium iodide. J.\u00a0Androl. 1994;15:620\u2013629.", "ArticleIdList": ["7721666"]}, {"Citation": "Abdullah S.M., Flath B., Presber H.W. Comparison of different staining procedures for the flow cytometric analysis of U-937 cells infected with different Leishmania-species. J.\u00a0Microbiol. Methods. 1999;37:123\u2013138.", "ArticleIdList": ["10445312"]}, {"Citation": "Bodley A.L., McGarryMW, Shapiro T.A. Drug cytotoxicity assay for African trypanosomes and Leishmania species. J.\u00a0Infect. Dis. 1995;172:1157\u20131159.", "ArticleIdList": ["7561203"]}, {"Citation": "Macarron R. Critical review of the role of HTS in drug discovery. Drug Discov. Today. 2006;11:277\u2013279.", "ArticleIdList": ["16580969"]}, {"Citation": "Alc\u00e2ntara L.M., Ferreira T., Fontana V., Chatelain E., Moraes C.B., Freitas-Junior L.H. A\u00a0multi-species phenotypic screening assay for leishmaniasis drug discovery shows that active compounds display a high degree of species-specificity. Molecules. 2020;25(11):2551.", "ArticleIdList": ["PMC7321149", "32486239"]}, {"Citation": "Okuno T., Goto Y., Matsumoto Y., Otsuka H., Matsumoto Y. Applications of recombinant Leishmania amazonensis expressing egfp or the beta-galactosidase gene for drug screening and histopathological analysis. Exp. Anim. 2003;52:109\u2013118.", "ArticleIdList": ["12806885"]}, {"Citation": "Reim\u00e3o J.Q., Oliveira J.C., Trinconi C.T., Cotrim P.C., Coelho A.C., Uliana S.R.B. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging. PLoS Neglected Trop. Dis. 2015;9", "ArticleIdList": ["PMC4332486", "25679212"]}, {"Citation": "Cannet A., Akhoundi M., Michel G., Marty P., Delaunay P. Experimental infection of Phlebotomus perniciosus by bioluminescent Leishmania infantum using murine model and artificial feeder. Mem. Inst. Oswaldo Cruz. 2016;111:495\u2013500.", "ArticleIdList": ["PMC4981113", "27439032"]}, {"Citation": "Coelho A.C., Oliveira J.C., Espada C.R., Reim\u00e3o J.Q., Trinconi C.T., Uliana S.R.B. A\u00a0luciferase-expressing Leishmania braziliensis line that leads to sustained skin lesions in BALB/c mice and allows monitoring of miltefosine treatment outcome. PLoS Neglected Trop. Dis. 2016;10", "ArticleIdList": ["PMC4856402", "27144739"]}, {"Citation": "Oliveira J.C., da Silva A.C., Oliveira R.A.D.S., Pereira V.R.A., Gil L.H.V.G. In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice. J.\u00a0Microbiol. Methods. 2016;130:189\u2013195.", "ArticleIdList": ["27498229"]}, {"Citation": "Melo G.D., Goyard S., Lecoeur H., Rouault E., Pescher P., Fiette L., Boissonnas A., Minoprio P., Lang T. New insights into experimental visceral leishmaniasis: real-time in vivo imaging of Leishmania donovani virulence. PLoS Neglected Trop. Dis. 2017;11", "ArticleIdList": ["PMC5629011", "28945751"]}, {"Citation": "Rouault E., Lecoeur H., Meriem A. Ben, Minoprio P., Goyard S., Lang T. Imaging visceral leishmaniasis in real time with golden hamster model: monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host. Parasitol. Int. 2017;66:933\u2013939.", "ArticleIdList": ["27794505"]}, {"Citation": "Alc\u00e2ntara L.M., Ferreira T.C.S., Gadelha F.R., Miguel D.C. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis. Int J Parasitol Drugs Drug Resist. 2018;8(3):430\u2013439.", "ArticleIdList": ["PMC6195035", "30293058"]}, {"Citation": "Kennedy J., Flemer B., Jackson S.A., Lejon D.P.H., Morrissey J.P., O\u2019Gara F. Marine metagenomics: new tools for the study and exploitation of marine microbial metabolism. Mar. Drugs. 2010;8:608\u2013628.", "ArticleIdList": ["PMC2857354", "20411118"]}, {"Citation": "Rath C.M., Janto B., Earl J., Ahmed A., Hu F.Z., Hiller L. Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. ACS Chem. Biol. 2011;6(11):1244\u20131256.", "ArticleIdList": ["PMC3220770", "21875091"]}, {"Citation": "Manivasagan P., Venkatesan J., Sivakumar K., Kim S.-K. Pharmaceutically active secondary metabolites of marine actinobacteria. Microbiol. Res. 2014;169(26):262\u2013278.", "ArticleIdList": ["23958059"]}, {"Citation": "Riesenfeld C.S., Schloss P.D., Handelsman J. Metagenomics: genomic analysis of microbial communities. Annu. Rev. Genet. 2004;38:525\u2013552.", "ArticleIdList": ["15568985"]}, {"Citation": "Venter J.C., Remington K., Heidelberg J.F., Halpern A.L., Rusch D., Eisen J.A. Environmental genome shotgun sequencing of the Sargasso Sea. Science. 2004;304:66\u201374.", "ArticleIdList": ["15001713"]}, {"Citation": "Bull A.T., Stach J.E.M., Ward A.C., Goodfellow M. Marine actinobacteria: perspectives, challenges, future directions. Antonie Leeuwenhoek. 2005;87:65\u201379.", "ArticleIdList": ["15971359"]}, {"Citation": "Kamble P., Vavilala S.L. Discovering novel enzymes from marine ecosystems: a metagenomic approach. Bot. Mar. 2018;61:161\u2013175."}, {"Citation": "Malik S., Beer M., Megharaj M., Naidu R. The use of molecular techniques to characterize the microbial communities in contaminated soil and water. Environ. Int. 2008;34:265\u2013276.", "ArticleIdList": ["18083233"]}, {"Citation": "Prichystal J., Schug K.A., Lemr K., Novak J., Havlicek V. Structure analysis of natural products. Anal. Chem. 2016;88:10338\u201310346.", "ArticleIdList": ["27661090"]}, {"Citation": "Mitchell A.L., Scheremetjew M., Denise H., Potter S., Tarkowska A., Qureshi M. EBI Metagenomics in 2017: enriching the analysis of microbial communities, from sequence reads to assemblies. Nucleic Acids Res. 2018;46:D726\u2013D735.", "ArticleIdList": ["PMC5753268", "29069476"]}, {"Citation": "Monciardini P., Sosio M., Cavaletti L., Chiocchini C., Donadio S. New PCR primers for the selective amplification of 16S rDNA from different groups of actinomycetes. FEMS Microbiol. Ecol. 2002;42:419\u2013429.", "ArticleIdList": ["19709301"]}, {"Citation": "Das M., Royer T.V., Leff L.G. Diversity of fungi, bacteria, and actinomycetes on leaves decomposing in a stream. Appl. Environ. Microbiol. 2007;73(3):756\u2013767.", "ArticleIdList": ["PMC1800785", "17142366"]}, {"Citation": "Sun W., Zhang F., He L., Karthik L., Li Z. Actinomycetes from the South China Sea sponges: isolation, diversity and potential for aromatic polyketides discovery. Front. Microbiol. 2010;6:1048.", "ArticleIdList": ["PMC4589764", "26483773"]}, {"Citation": "Mincer T.J., Fenical W., Jensen P.R. Culture-dependent and culture-independent diversity within the obligate marine actinomycete genus Salinispora. Appl. Environ. Microbiol. 2005;71(11):7019\u20137028.", "ArticleIdList": ["PMC1287694", "16269737"]}, {"Citation": "Stach J.E.M., Maldonado L.A., Ward A.C., Goodfellow M., Bull A.T. New primers for the class Actinobacteria: application to marine and terrestrial environments. Environ. Microbiol. 2003;5(10):828\u2013841.", "ArticleIdList": ["14510836"]}, {"Citation": "Riedlinger J., Reicke A., Z\u00e4hner H., Krismer B., Bull A.T., Maldonado L.A. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J.\u00a0Antibiot. 2004;57(4):271.", "ArticleIdList": ["15217192"]}, {"Citation": "Wawrik B., Kerkhof L., Zylstra G.J., Kukor J.J. Identification of unique type II polyketide synthase genes in soil. Appl. Environ. Microbiol. 2005;71(5):2232\u20132238.", "ArticleIdList": ["PMC1087561", "15870305"]}, {"Citation": "Nimnoi P., Pongsilp N., Lumyong S. Genetic diversity and community of endophytic actinomycetes within the roots of Aquilaria crassna Pierre ex Lec assessed by Actinomycetes-specific PCR and PCR-DGGE of 16S rRNA gene. Biochem. Systemat. Ecol. 2010;38(4):595\u2013601."}, {"Citation": "Andrade M.A., Ponting C.P., Gibson T.J., Bork P. Homology based method for identification of protein repeats using statistical significance estimates. J.\u00a0Mol. Biol. 2000;298:521\u2013537.", "ArticleIdList": ["10772867"]}, {"Citation": "Niu G. Genomics-driven natural product discovery in Actinomycetes. Trends Biotechnol. 2018;36:238\u2013241.", "ArticleIdList": ["29126570"]}, {"Citation": "Shokralla S., Spall J., Gibson J., Hajibabaei M. Next-generation sequencing technologies for environmental DNA research. Mol. Ecol. 2012;21:1794\u20131805.", "ArticleIdList": ["22486820"]}, {"Citation": "Mahapatra G.P., Raman S., Nayak S., Gouda S., Das G., Patra J.K. Metagenomics approaches in discovery and development of new bioactive compounds from marine actinomycetes. Curr. Microbiol. 2019:1\u201312.", "ArticleIdList": ["31069462"]}, {"Citation": "Yang N., Song F. Bioprospecting of novel and bioactive compounds from marine actinomycetes isolated from South China Sea sediments. Curr. Microbiol. 2017", "ArticleIdList": ["28918535"]}, {"Citation": "Hindra H.T., Yang D., Rudolf J.D., Xie P., Xie G., Teng Q., Lohman J.R., Zhu X., Huang Y., Zhao L.X., Jiang Y., Duan Y., Shen B. Strain prioritization for natural product discovery by a high-throughput Realtime PCR method. J.\u00a0Nat. Prod. 2014;77:2296\u20132303.", "ArticleIdList": ["PMC4208669", "25238028"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "5", "Day": "21"}, {"Year": "2021", "Month": "7", "Day": "25"}, {"Year": "2021", "Month": "7", "Day": "30"}, {"Year": "2021", "Month": "8", "Day": "19", "Hour": "6", "Minute": "46"}, {"Year": "2021", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "8", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["34409179", "PMC8361068", "10.1016/j.heliyon.2021.e07710", "S2405-8440(21)01813-2"]}}], "PubmedBookArticle": []}